(Q39642049)

English

Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival

scientific article published on 20 October 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A N Cornforth

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

A W Fowler

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

D J Carbonell

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

R O Dillman

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

20 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

60

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

123-131

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Taming cancer by inducing immunity via dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Current approaches in dendritic cell generation and future implications for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Clinical applications of dendritic cell vaccination in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Autologous melanoma vaccine induces antitumor and self-reactive immune responses that affect patient survival and depend on MHC class II expression on vaccine cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Interferon-gamma treatment of B16 melanoma cells: opposing effects for non-adaptive and adaptive immune defense and its reflection by metastatic spread

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon-gamma.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Tumor stress, cell death and the ensuing immune response.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Calreticulin exposure dictates the immunogenicity of cancer cell death

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Modes of calreticulin recruitment to the major histocompatibility complex class I assembly pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Interferons induce tyrosine phosphorylation of the eIF2alpha kinase PKR through activation of Jak1 and Tyk2.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Short-term tumor cell lines from renal cell carcinoma for use as autologous tumor cell vaccines in the treatment of kidney cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Development of IFN-gamma resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Migration of dendritic cell based cancer vaccines: in vivo veritas?

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Immunogenic cell death modalities and their impact on cancer treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Chemotherapy induces ATP release from tumor cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

TLR signalling and the function of dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Signals from dying cells: tolerance induction by the dendritic cell

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Interferon-gamma and anti-Fas antibody-induced apoptosis in human melanoma cell lines and its relationship to bcl-2 cleavage and bak expression

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Molecular characteristics of immunogenic cancer cell death.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Radiation induces an antitumour immune response to mouse melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Patient-specific vaccines derived from autologous tumor cell lines as active specific immunotherapy: results of exploratory phase I/II trials in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0925-Y

21 January 2018

Identifiers

10.1007/S00262-010-0925-Y

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39642049&oldid=2203049963"